|
Ingelheim Pharmaceuticals (Pty) Ltd, Suite 1, Building 4, 2nd Floor, Waterfall Corporate Campus, 74 Waterfall Drive, Midrand, 2066. Cpy Reg. No. 1966/008618/07. BI Ref. No: SC-ZA-02310. Expiry Date: August 2024
This meeting is intended for healthcare professionals only and the invitation is not transferable. Spouses, non-medical professionals and children may not enter the conference room - any costs related to their presence is for their own account. This venue is for conference use only - any additional activities are for your own expense (example spa, telephone calls, laundry etc. is not included).
Pharmacovigilance: Health Care physicians can report any adverse event (lack of efficacy, off label use, overdose with or without AE, medication error with or without AE, drug abuse/misuse, drug interaction, occupational exposure, pregnancy/lactation exposure and therapeutical response increase and/or unexpected benefit) occurring during or after administration of a marketed Boehringer Ingelheim product they become aware of either by written or verbal means by contacting Boehringer Ingelheim’s responsible Pharmacovigilance unit using the below contact details:
|
|